Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer

The phosphoinositide 3-kinase (PI3K) pathway is activated in most advanced prostate cancers, yet so far treatments with PI3K inhibitors have been at best tumorostatic in preclinical cancer models and do not show significant antitumor efficacy in clinical trials. Results from tissue culture experimen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Baiz, Daniele, Hassan, Sazzad, Choi, Young A, Flores, Anabel, Karpova, Yelena, Yancey, Dana, Pullikuth, Ashok, Sui, Guangchao, Sadelain, Michel, Debinski, Waldemar, Kulik, George
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Neoplasia Press Inc. 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3819633/
https://ncbi.nlm.nih.gov/pubmed/24204196
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak